| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2012 | US20120029002 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases |
| 02/02/2012 | US20120029001 Method of treatment of nephrogenic diabetes insipidus |
| 02/02/2012 | US20120029000 Process for the preparation of alogliptin |
| 02/02/2012 | US20120028999 Administration of tlr7 ligands and prodrugs thereof for treatment of infection by hepatitis c virus |
| 02/02/2012 | US20120028998 Co-crystal of etravirine and nicotinamide |
| 02/02/2012 | US20120028997 Prokineticin 1 receptor antagonists |
| 02/02/2012 | US20120028996 Novel oxime derivatives |
| 02/02/2012 | US20120028995 Novel compounds for medical use as peptidase effectors |
| 02/02/2012 | US20120028994 Compounds for the reduction of beta-amyloid production |
| 02/02/2012 | US20120028993 Compounds Effective Against Cancer |
| 02/02/2012 | US20120028992 Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| 02/02/2012 | US20120028991 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands |
| 02/02/2012 | US20120028990 3 aryl or heteroaryl-substituted indole derivative |
| 02/02/2012 | US20120028989 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines |
| 02/02/2012 | US20120028987 Bicyclic Benzamides of 3-Or-4-Substituted 4-(Aminomethyl)-Piperidine Derivatives |
| 02/02/2012 | US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors |
| 02/02/2012 | US20120028985 Combinational therapy for treating autoimmune disease |
| 02/02/2012 | US20120028984 Compound Useful As A c-MET Inhibitor |
| 02/02/2012 | US20120028983 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same |
| 02/02/2012 | US20120028982 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative |
| 02/02/2012 | US20120028981 Kinase Knockdown Via Electrophilically Enhanced Inhibitors |
| 02/02/2012 | US20120028980 Use of nk-1 receptor antagonists in management of visceral pain |
| 02/02/2012 | US20120028979 2-(piperidin-1-yl)-4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections |
| 02/02/2012 | US20120028978 Substituted bicyclic hcv inhibitors |
| 02/02/2012 | US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions |
| 02/02/2012 | US20120028976 Pharmacokinetically-based dosing regiments of a thrombin receptor antagonist |
| 02/02/2012 | US20120028975 Substituted triazolopyridines and analogs thereof |
| 02/02/2012 | US20120028974 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 02/02/2012 | US20120028973 Nitroimidazooxazines and their uses in anti-tubercular therapy |
| 02/02/2012 | US20120028972 Biomarker assays for detecting or measuring inhibition of tor kinase activity |
| 02/02/2012 | US20120028971 Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof |
| 02/02/2012 | US20120028970 Heteroarylthiomethyl pyridine derivative |
| 02/02/2012 | US20120028969 Bicyclic acetyl-coa carboxylase inhibitors and uses thereof |
| 02/02/2012 | US20120028968 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use |
| 02/02/2012 | US20120028967 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use |
| 02/02/2012 | US20120028966 Protein kinase inhibitors |
| 02/02/2012 | US20120028965 Compounds useful as protein kinase inhibitors |
| 02/02/2012 | US20120028964 Pharmaceutical combination |
| 02/02/2012 | US20120028963 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
| 02/02/2012 | US20120028962 Fused heterocyclic ring compound |
| 02/02/2012 | US20120028961 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist |
| 02/02/2012 | US20120028960 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| 02/02/2012 | US20120028959 Dihydroorotate dehydrogenase inhibitors |
| 02/02/2012 | US20120028958 5-alkynyl-pyrimidines |
| 02/02/2012 | US20120028957 Inhibitors Of The Influenza A Virus M2 Proton Channel |
| 02/02/2012 | US20120028956 Bicyclic mglur5 positive allosteric modulators and methods of making and using same |
| 02/02/2012 | US20120028955 Bicyclic mglur5 positive allosteric modulators and methods of making and using same |
| 02/02/2012 | US20120028954 Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same |
| 02/02/2012 | US20120028953 Azetidine Derivatives |
| 02/02/2012 | US20120028952 5-alkynyl-pyrimidines |
| 02/02/2012 | US20120028951 Pyridazinone compounds |
| 02/02/2012 | US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof |
| 02/02/2012 | US20120028949 Rapidly Disintegrating Tablet |
| 02/02/2012 | US20120028948 Testosterone gel and method of use |
| 02/02/2012 | US20120028947 Ophthalmic Compositions |
| 02/02/2012 | US20120028946 Testosterone gel and method of use |
| 02/02/2012 | US20120028945 5-Beta, 14-Beta-Androstane Derivatives Useful For The Treatment Of Proteinuria, Glomerulosclerosis And Renal Failure |
| 02/02/2012 | US20120028944 Cyclodextrin nanotechnology for ophthalmic drug delivery |
| 02/02/2012 | US20120028943 Medicinal Cream Made Using Fluticasone Propionate And Chitosan And A Process To Make The Same |
| 02/02/2012 | US20120028942 Medicinal Cream Made Using Neomycin Sulphate, Betamethasone Valerate, And Chitosan, And A Process To Make The Same |
| 02/02/2012 | US20120028941 Pharmaceutical Product Comprising a P38 Kinase Inhibitor and a Second Active Ingredient |
| 02/02/2012 | US20120028940 Functionally selective azanitrile alpha-2c adrenoreceptor agonists |
| 02/02/2012 | US20120028939 Substituted naphthyridines and their use as medicaments |
| 02/02/2012 | US20120028938 Pyrazole compounds as crth2 antagonists |
| 02/02/2012 | US20120028937 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 02/02/2012 | US20120028936 Oral contraception with trimegestone |
| 02/02/2012 | US20120028935 Therapeutic Gestagens for the Treatment of Premenstrual Dysphoric Disorder |
| 02/02/2012 | US20120028934 STABLE PHARMACOLOGICALLY ACTIVE COMPOSITIONS INCLUDING VITAMIN D-CONTAINING AND CORTICOSTEROID COMPOUNDS WITH LOW pH COMPATIBILITY |
| 02/02/2012 | US20120028933 Cell Culture Media Supplement and Method of Molecular Stress Control |
| 02/02/2012 | US20120028932 Drug combinations containing pde4 inhibitors and nsaids |
| 02/02/2012 | US20120028931 Heterocyclic m-glu5 antagonists |
| 02/02/2012 | US20120028930 Flupirtine salts and polymorphs |
| 02/02/2012 | US20120028929 Tetracycline stabilizing formulations |
| 02/02/2012 | US20120028928 Process for Isolating Tigecycline and Tigecycline Made Therefrom |
| 02/02/2012 | US20120028927 Novel Triazene Compounds For The Treatment Of Cancer |
| 02/02/2012 | US20120028926 Phosphate Management with Small Molecules |
| 02/02/2012 | US20120028925 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 02/02/2012 | US20120028924 Chemical compounds |
| 02/02/2012 | US20120028923 Compositions and methods for inhibition of the jak pathway |
| 02/02/2012 | US20120028922 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| 02/02/2012 | US20120028921 Methods and compositions using oxidized phospholipids |
| 02/02/2012 | US20120028920 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 02/02/2012 | US20120028919 Pyrrolotriazines as alk and jak2 inhibitors |
| 02/02/2012 | US20120028918 Pharmaceutical compositions and methods of making same |
| 02/02/2012 | US20120028917 Use Of N-(4-((3-(2-Amino-4-Pyrimidinyl)-2-Pyridinyl)Oxy)Phenyl)-4-(4-Methyl-2-Thienyl)-1-Phthalazinamine In The Treatment Of Antimitotic Agent Resistant Cancer |
| 02/02/2012 | US20120028916 Cosmetic compositions comprising oridonin and new cosmetic uses |
| 02/02/2012 | US20120028915 6"-amino-6"-deoxygalactosylceramides |
| 02/02/2012 | US20120028914 Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
| 02/02/2012 | US20120028912 Methods of modulating bromodomains |
| 02/02/2012 | US20120028911 Mucin Derived Polypeptides |
| 02/02/2012 | US20120028908 Methods of Manufacturing Crystalline Forms of Rapamycin Analogs |
| 02/02/2012 | US20120028907 Methods for identification of tumor phenotype and treatment |
| 02/02/2012 | US20120028906 Method for affecting the timing of cervical ripening and for parturition |
| 02/02/2012 | US20120028900 Method of producing factor viii proteins by recombinant methods |
| 02/02/2012 | US20120028892 Inhibitors of fructose 1,6-bisphosphatase and methods of use thereof |
| 02/02/2012 | US20120028889 Integrase cofactor |
| 02/02/2012 | US20120028371 Method and kit for detecting the early onset of renal tubular cell injury |
| 02/02/2012 | US20120028312 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference |
| 02/02/2012 | US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 02/02/2012 | US20120028258 Receptor gene screening for detecting or diagnosing cancer |